Literature DB >> 26617909

Genetic association between CD44 polymorphisms and chronic hepatitis B virus infection in a Chinese Han population.

Fan Li1, Qing Shao1, Dong Ji1, Bing Li1, Guofeng Chen1.   

Abstract

AIMS: This article aimed at discussing the association of chronic hepatitis B virus (HBV) infection with CD44 polymorphisms in Chinese Han population; meanwhile, the interaction of polymorphisms was also analyzed based on chronic HBV infection.
METHODS: The genotyping of CD44 polymorphisms was conducted by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) in 108 HBV infected and 130 healthy persons. The genotype distributions of CD44 rs187115, rs13347 in the control group were checked by Hardy-Weinberg equilibrium (HWE). The strength of the relevance between polymorphism and disease was measured by odds ratio (OR) with corresponding 95% confidence interval (CI) calculated by χ(2) test. The 2×4 crossover analysis method was used to conduct the interaction analysis of polymorphisms.
RESULTS: The genotype distributions in controls conformed to HWE. GG genotype and G allele frequencies in rs187115 were obviously higher in cases than the controls (P=0.02, 0.04). Compared with the common genotype CC, individual who carried mutant genotypes (CT and TT) of rs13347 had a significantly high risk to suffer from HBV infection (OR=1.99, P=0.02 for CT; OR=3.56, P=3.00×10(-3) for TT), furthermore, CT+TT genotype also showed a high susceptibility (OR=2.27, P=2.00×10(-3)). Similarly, T allele of rs13347 increased 0.98 times risk in cases compared with controls (OR=1.98, 95% CI=1.34-2.92). The two polymorphisms in CD44 presented a positive interaction.
CONCLUSION: CD44 polymorphisms are associated with chronic HBV infection as the risk factors, and the synergistic action is also found between the two polymorphisms.

Entities:  

Keywords:  CD44; chronic hepatitis B virus infection; polymorphism

Mesh:

Substances:

Year:  2015        PMID: 26617909      PMCID: PMC4637725     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  27 in total

Review 1.  Current status and prospects of studies on human genetic alleles associated with hepatitis B virus infection.

Authors:  Fu-Sheng Wang
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

2.  Genomic heterogeneity of hepatitis B virus (HBV) and outcome of perinatal HBV infection.

Authors:  Irene Cacciola; Giovanni Cerenzia; Teresa Pollicino; Giovanni Squadrito; Stefania Castellaneta; Alessando R Zanetti; Giorgina Mieli-Vergani; Giovanni Raimondo
Journal:  J Hepatol       Date:  2002-03       Impact factor: 25.083

Review 3.  CD44 cell adhesion molecules.

Authors:  S Goodison; V Urquidi; D Tarin
Journal:  Mol Pathol       Date:  1999-08

Review 4.  Hepatitis B virus replication and liver disease progression: the impact of antiviral therapy.

Authors:  Yun-Fan Liaw
Journal:  Antivir Ther       Date:  2006

5.  Genetic protection against hepatitis B virus conferred by CCR5Delta32: Evidence that CCR5 contributes to viral persistence.

Authors:  Chloe L Thio; Jacquie Astemborski; Arman Bashirova; Timothy Mosbruger; Spencer Greer; Mallory D Witt; James J Goedert; Margaret Hilgartner; Audrey Majeske; Stephen J O'Brien; David L Thomas; Mary Carrington
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

Review 6.  Immunology of hepatitis B and hepatitis C virus infections.

Authors:  Andre Boonstra; Andrea M Woltman; Harry L A Janssen
Journal:  Best Pract Res Clin Gastroenterol       Date:  2008       Impact factor: 3.043

7.  Association between vitamin D receptor, CCR5, TNF-alpha and TNF-beta gene polymorphisms and HBV infection and severity of liver disease.

Authors:  Pothakamuri Venkata Suneetha; Shiv Kumar Sarin; Ankur Goyal; Gollapudi Tharun Kumar; Deepak Kumar Shukla; Syed Hissar
Journal:  J Hepatol       Date:  2006-02-21       Impact factor: 25.083

8.  Genetic association of osteopontin (OPN) and its receptor CD44 genes with susceptibility to Chinese gastric cancer patients.

Authors:  Yue Qiu; Yuan Hu; Zuo-Yang Zhang; Lei Ye; Fei-Hong Xu; Marion E Schneider; Xue-Ling Ma; Yi-Xin Du; Xian-Bo Zuo; Fu-Sheng Zhou; Gang Chen; Xu-Shi Xie; Yan Zhang; Hong-Zhen Xia; Ji-Feng Wu; Wei-Dong Du
Journal:  J Cancer Res Clin Oncol       Date:  2014-07-10       Impact factor: 4.553

9.  Host genetic factors and vaccine-induced immunity to HBV infection: haplotype analysis.

Authors:  Kelli K Ryckman; Katherine Fielding; Adrian V Hill; Maimuna Mendy; Pura Rayco-Solon; Giorgio Sirugo; Marianne A van der Sande; Pauline Waight; Hilton C Whittle; Andrew J Hall; Scott M Williams; Branwen J Hennig
Journal:  PLoS One       Date:  2010-08-18       Impact factor: 3.240

Review 10.  The Role of CD44 in Disease Pathophysiology and Targeted Treatment.

Authors:  Andre R Jordan; Ronny R Racine; Martin J P Hennig; Vinata B Lokeshwar
Journal:  Front Immunol       Date:  2015-04-21       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.